CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly

ML Generative Models AI4S DSMSD
分子偶联物(包括PROTAC和多肽-药物偶联物PDC)的功能源于其多个耦合组分的协同作用;然而,目前大多数生成式方法均独立设计各组分,仅在生成完成后再进行组装。此类分阶段流水线式方法忽略了组分间的跨组分依赖关系,往往导致所生成的偶联物存在化学结构无效、偏离实测偶联物分布范围,或组装后丧失功能等问题。本研究提出了“面向偶联物组装的耦合目标引导离散流生成方法”(CupOFMoCA),这是一种离散型生成模型,可在偶联物生成过程中显式施加跨组分的化学约束。CupOFMoCA将引导式更新严格限定于化学上可行的偶联物状态,并依据分子设计目标对局部转移概率进行重加权。在三个PDC体系上的实验表明:采用耦合式生成策略后,所有有效多肽所对应的偶联物100%满足共价连接有效性要求,且其有效产出率显著高于匹配的“先生成后过滤”策略;同时,在全部有效偶联物集合中,其预测结合得分与对照方法相当。在针对三个PROTAC体系开展的三种子集评估中,CupOFMoCA在其中两个体系上实现了最高的组装有效性,并在单位时间内生成的组装有效分子数量上超越所有对比基线方法。我们进一步采用DegradeMaster对生成的PROTAC分子进行事后评分,并结合显式溶剂分子动力学模拟对其展开评估,结果支持了模型对其降解活性及构象特性的预测可靠性。综上所述,本研究证实CupOFMoCA是一种高效、可靠的分子偶联物生成工具,可通过协同调控偶联物组装过程与分子性质,有力支撑靶向蛋白降解等新型治疗策略的研发进程。
Molecular conjugates, including PROTACs and peptide-drug conjugates (PDCs), derive their function from the joint behavior of multiple coupled components, yet most generative approaches design these components independently and combine them only after generation. Such staged pipelines ignore cross-component dependencies and often produce conjugates that are chemically invalid, fall outside empirical conjugate distributions, or lose function upon assembly. In this work, we introduce Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly (CupOFMoCA), a discrete generative method that enforces cross-component chemical constraints during conjugate generation. CupOFMoCA restricts guided updates to chemically feasible conjugate states and reweights local transitions using molecular design objectives. Across three PDC systems, coupled generation achieved 100% conjugation validity among valid peptides and increased valid yield over matched post-hoc filtering, with comparable predicted binding scores across the full valid sets. In three-seed evaluations of three PROTAC systems, CupOFMoCA achieved the highest assembly validity on two systems and generated more assembly-valid molecules per second than the evaluated baselines. We further evaluated the generated PROTACs with post-hoc DegradeMaster scoring and explicit-solvent molecular dynamics, supporting their predicted activity and conformational properties. Together, these results establish CupOFMoCA as an efficient generator of molecular conjugates, supporting therapeutic development via coordinated control of assembly and molecular properties.
许愿